The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 89.60
Bid: 89.20
Ask: 93.60
Change: 2.60 (2.99%)
Spread: 4.40 (4.933%)
Open: 87.40
High: 95.00
Low: 87.40
Prev. Close: 87.00
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Oct 2023 10:27

RNS Number : 0807Q
De La Rue PLC
13 October 2023
 

De La Rue plc

(the "Company")

 

Director/PDMR Shareholding

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

13 October 2023

De La Rue plc announces that on 12 October 2023 it granted awards under the De La Rue Performance Share Plan 2020 (the "PSP") and the De La Rue Investor Returns Plan (the "IRP") to Clive Vacher and Ruth Euling, each of whom is an Executive Director and a Person Discharging Managerial Responsibilities ("PDMR") of the Company. The granting of the awards creates a change in the interests of each of them in the ordinary shares of 44152/175p of the Company ("Shares"). The awards were granted under the rules of the PSP and IRP as follows:

Name of Director/PDMR

Role

Number of Shares subject to the PSP Option

(40% of the award)

Number of Shares subject to the IRP Option

(60% of the award)

Clive Vacher

CEO

309,602

640,878

Ruth Euling

MD, Currency

102,454

212,079

 

The Options were granted on 12 October 2023 (the "Award Date"). The number of Shares contained in each Option was calculated by reference to a price of 62 pence, being the average of the closing middle market quotations for the Company's Shares for the five consecutive dealing days including and ending on 11 October 2023. 

The awards are a blended mix of PSP and IRP Options offering higher leverage and potential returns to participants for associated share price growth.

The PSP Options are granted such that vesting is subject to two equally-weighted performance conditions, which will be assessed independently, as outlined below:

Performance metric

Proportion

Threshold

Maximum

Outcome

25% vesting

100% vesting

Adjusted EPS (Average performance over 3 years)

50%

3 pence

5 pence

Free Cash Flow (3 year average)

50%

£10million

£15 million

 

Performance below Threshold will result in zero vesting. Performance between the Threshold and Maximum levels will result in a pro-rata increase in the number of Shares vesting, on a straight-line basis. Performance beyond the Maximum level will not result in any additional vesting.

The IRP Options are granted subject to the following performance condition:

Relative Total Shareholder Return Underpin

Outperformance of the FTSE 250 (ex Investment Trusts) over the three years from date of grant.

Calculated based on a net return index with 30 day averaging at the start and end of the performance period.

Equivalent to 60% of award on a relative face value calculation

100% will vest if underpin met

However, as the exercise price is set at a premium to the share price at grant, participants will only be able to realise value if the share price exceeds 80p.

 

Options under the IRP will only have value if the share price exceeds the option price and vesting requires that the Company has delivered market competitive total returns to shareholders. The exercise price has been set at 80p (a premium of 29% to the share price of 62p at grant date).

The performance conditions are also subject to the discretion of the Remuneration Committee to adjust or over-ride the formulaic outcome and determine the number of Shares in respect of which the Option will vest, taking into account such factors it may in its discretion determine, potentially including the underlying performance of the Group and the Participant's individual performance.

 

The normal vesting date for each of the Options is 12 October 2026. To the extent that an Option vests, it is subject to a further holding period of two years, during which time it will not be capable of exercise. This means that, in line with the UK Corporate Governance Code, each Option will be subject to an aggregate vesting and holding period of five years and no value can be realized by the option holder until 12 October 2028 at the earliest.

 

The number of Shares shown in the first table above represents the maximum that may be acquired if all performance conditions are achieved in full. The Company may also transfer additional Shares to reflect the value of dividends that would have been paid on the Shares in respect of which the Option vests over the period between the Award Date and the end of the post-vesting holding period.

The relevant information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation as retained in UK law.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Clive Vacher

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

Grant of options under the rules of the De La Rue Performance Share Plan 2020 (PSP) and the De La Rue Investor Returns Plan (IRP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.00

 

PSP: 309,602

IRP: 640,878

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

12 October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ruth Euling

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/MD, Currency

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

Grant of options under the rules of the De La Rue Performance Share Plan 2020 (PSP) and the De La Rue Investor Returns Plan (IRP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.00

 

PSP: 102,454

IRP: 212,079

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

12 October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

Jon Messent, Company Secretary

Contact Number: 01256 605212

13 October 2023

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANEDFASDFEA
Date   Source Headline
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.